[Evaluation of the clinical efficacy and tolerance of a formulation of 2% tioconazole cream versus 1% tioconazole cream in the treatment of dermatomycoses].
Tulli
A
A
D000279:Administration, Cutaneous; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009824:Ointments
D000935:Antifungal Agents; D007093:Imidazoles; D009824:Ointments; C020527:tioconazole
Valutazione dell'efficacia clinica e della tollerabilità di una formulazione di tioconazolo crema 2% vs tioconazolo crema 1% nella terapia delle dermatomicosi.